Trusted and required by the United States FDA and Japan’s PMDA, CDISC facilitates the review process and expedites approval times for more efficient and effective clinical research. Requiring standardized data enables regulators to modernize the review process with a more consistent use of analysis tools to better view drug data and highlight areas of concern.
- Clear and consistent data: Ensuring all data submitted is standardized reaffirms the data you are reviewing is consistent and clear.
- Expedited treatments to patients: As we continue our quest for global awareness and adoption of our standards, with your help, we can find ever-better ways to create a shared language that increases visibility into data and brings better, safer drugs to patients more quickly.
- Quality standards: For over 20 years, we've taken a rigorous approach to developing and advancing data standards that are open and available for all. Each standard is informed and shaped by the expertise of those at the forefront of clinical research today, making them not just of the highest quality, but also attuned to the practicalities of their implementation.